HomeCHM • ASX
Follow
Chimeric Therapeutics Ltd
Previous close
$0.028
Day range
$0.027 - $0.030
Year range
$0.023 - $0.086
Market cap
23.74M AUD
Avg Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.49M | 264.48% |
Operating expense | 4.61M | -37.15% |
Net income | 1.22M | 120.80% |
Net profit margin | 22.28 | 105.71% |
Earnings per share | — | — |
EBITDA | 1.12M | 120.09% |
Effective tax rate | -3.08% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.53M | -2.78% |
Total assets | 26.69M | 18.51% |
Total liabilities | 12.83M | 95.37% |
Total equity | 13.86M | — |
Shares outstanding | 725.84M | — |
Price to book | 1.40 | — |
Return on assets | 8.23% | — |
Return on capital | 15.84% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.22M | 120.80% |
Cash from operations | -2.34M | 63.08% |
Cash from investing | 11.72K | 50.31% |
Cash from financing | 2.94M | 362.61% |
Net change in cash | 581.38K | 107.88% |
Free cash flow | 1.01M | 138.12% |
About
Founded
2020
Website